by In2Pharma | Oct 17, 2024 | News
The Netherlands From 1 October 2024, recall notices and DHPCs will be distributed by e-mail as much as possible. In the past, marketing authorisation holders send these risk communications by post to healthcare professionals in special “Orange Hand” envelopes (for...
